本次传出出售博士伦的消息，或许与博士康的当下困境密不可分。据报道，博士康现有债务为210亿美元，其中100亿美元将在2027年底前到期。然而由于博士伦是重要的创收子公司，母公司必须通过偿付能力测试，然后才能批准出售。

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

While we all hope that businesses large and small are out in the world doing the best job possible to be scandal-free, it’s ...

Shares of Bausch + Lomb (NYSE: BLCO) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company ...

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant ...

根据最近的监管文件显示，Bausch Health Companies Inc. (NYSE:BHC)的执行副总裁兼总法律顾问Seana Carson出售了部分公司股票。2024年9月6日，Carson以平均6.21美元的价格出售了13,370股普通股，总计约83,027美元。 此次出售是根据Carson于2023年11月6日采用的Rule 10b5-1交易计划进行的。这类计划允许公司内部人员在预 ...

Andrew Left is fighting a range of criminal and civil charges related to his trading practices, and other investors who make ...

Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial ...

Bausch Health retained an 88 per cent shareholding in the eye care subsidiary after listing the group in 2022. But it planned ...

Report Ocean has published a new report on the Skincare Devices market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

Financial writers report on private equity interest in a potential takeover of Bausch & Lomb, with firms like Blackstone and ...